Aptus Capital Advisors LLC raised its holdings in shares of Chemed Corporation (NYSE:CHE - Free Report) by 12.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,624 shares of the company's stock after buying an additional 6,368 shares during the period. Aptus Capital Advisors LLC owned about 0.40% of Chemed worth $25,353,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Barclays PLC lifted its stake in shares of Chemed by 39.6% during the 3rd quarter. Barclays PLC now owns 22,874 shares of the company's stock worth $10,242,000 after acquiring an additional 6,485 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Chemed by 5.6% in the 3rd quarter. Dimensional Fund Advisors LP now owns 240,180 shares of the company's stock valued at $107,542,000 after acquiring an additional 12,810 shares during the last quarter. Cresset Asset Management LLC purchased a new stake in Chemed in the third quarter worth $204,000. Victory Capital Management Inc. lifted its position in shares of Chemed by 218.1% during the third quarter. Victory Capital Management Inc. now owns 8,652 shares of the company's stock worth $3,874,000 after purchasing an additional 5,932 shares during the last quarter. Finally, Focus Partners Advisor Solutions LLC bought a new stake in shares of Chemed during the third quarter worth $436,000. 95.85% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have recently commented on CHE shares. Jefferies Financial Group cut shares of Chemed from a "buy" rating to a "hold" rating in a report on Thursday, January 22nd. Weiss Ratings restated a "hold (c-)" rating on shares of Chemed in a research note on Wednesday, January 21st. Oppenheimer decreased their price target on shares of Chemed from $580.00 to $500.00 and set an "outperform" rating for the company in a research note on Friday, February 27th. Finally, Royal Bank Of Canada reiterated a "sector perform" rating and issued a $422.00 price target (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Two investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat.com, Chemed presently has an average rating of "Hold" and a consensus target price of $498.00.
Check Out Our Latest Stock Report on Chemed
Chemed Stock Up 0.3%
Shares of CHE stock opened at $412.36 on Friday. The firm has a market cap of $5.68 billion, a price-to-earnings ratio of 22.45, a PEG ratio of 1.63 and a beta of 0.46. Chemed Corporation has a 52-week low of $385.00 and a 52-week high of $623.60. The company's 50 day moving average is $444.70 and its 200 day moving average is $443.11.
Chemed (NYSE:CHE - Get Free Report) last posted its earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share for the quarter, missing analysts' consensus estimates of $7.02 by ($0.60). Chemed had a return on equity of 25.66% and a net margin of 10.48%.The company had revenue of $639.34 million for the quarter, compared to analysts' expectations of $659.09 million. During the same quarter in the prior year, the company earned $6.83 EPS. The firm's quarterly revenue was down .1% on a year-over-year basis. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. Analysts anticipate that Chemed Corporation will post 21.43 EPS for the current fiscal year.
Chemed Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Monday, February 23rd will be paid a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.6%. The ex-dividend date is Monday, February 23rd. Chemed's payout ratio is 13.06%.
Chemed Profile
(
Free Report)
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Further Reading
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A forward-looking investment report spotlighting the seven space companies best positioned to benefit from accelerating commercialization in 2026. It explores key industry trends, major growth catalysts, and the stocks shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
